Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dexcom (DXCM) Assets Average (2016 - 2026)

Dexcom has reported Assets Average over the past 16 years, most recently at $6.5 billion for Q1 2026.

  • Quarterly Assets Average fell 1.99% to $6.5 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $6.5 billion through Mar 2026, down 1.99% year-over-year, with the annual reading at $6.4 billion for FY2025, 0.59% up from the prior year.
  • Assets Average was $6.5 billion for Q1 2026 at Dexcom, down from $6.9 billion in the prior quarter.
  • Over five years, Assets Average peaked at $7.4 billion in Q3 2025 and troughed at $5.0 billion in Q1 2022.
  • The 5-year median for Assets Average is $6.4 billion (2023), against an average of $6.2 billion.
  • Year-over-year, Assets Average skyrocketed 32.62% in 2023 and then decreased 1.99% in 2026.
  • A 5-year view of Assets Average shows it stood at $5.1 billion in 2022, then rose by 24.97% to $6.4 billion in 2023, then dropped by 0.17% to $6.4 billion in 2024, then rose by 7.8% to $6.9 billion in 2025, then decreased by 6.26% to $6.5 billion in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Assets Average are $6.5 billion (Q1 2026), $6.9 billion (Q4 2025), and $7.4 billion (Q3 2025).